The following is a list of Multiple Sclerosis research studies that are currently enrolling participants.
Multiple Sclerosis Clinical Trials
A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis
Brain Plasticity/Repair Genes and Neuroimaging in MS
Long-term, prospective, observational, multinational,parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy